{"meta":{"query_hash":"8b687e27cfd6","filters":{"venue":"Journal of Crohn s and Colitis Supplements"},"cohort_total":15,"direct_labels_cover":0,"predictions_cover":15,"exported":15,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/8b687e27cfd6","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Crohn+s+and+Colitis+Supplements"},"results":[{"id":"W1979073250","doi":"10.1016/s1873-9954(09)70058-8","title":"P044 IDENTIFYING CHILDREN DIAGNOSED WITH IBD USING HEALTH ADMINISTRATIVE DATA: DEVELOPMENT OF THE ONTARIO CROHN'S AND COLITIS COHORT (OCCC)","year":2009,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cohort; Colitis; Crohn's disease; Internal medicine; Disease","score_opus":0.20609609435970558,"score_gpt":0.4456838337945426,"score_spread":0.23958773943483705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979073250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7253714,0.0005794432,0.0020507781,0.0024531847,0.00012545417,0.0012726493,0.25522706,0.00013570886,0.012784311],"genre_scores_gemma":[0.8742129,0.0005813014,0.0067114956,0.00053616724,0.00006569561,0.0015546266,0.10911312,0.00006981287,0.0071549835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985826,0.00022391313,0.00007991768,0.00012735258,0.00076723273,0.00021905203],"domain_scores_gemma":[0.9952567,0.00034041455,0.00092949515,0.000524195,0.0021298525,0.00081930484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018237534,0.00038547482,0.000329746,0.0018181344,0.0017662806,0.0008792874,0.0014999534,0.00054111885,0.003713692],"category_scores_gemma":[0.008346515,0.00041704832,0.00071756355,0.0033069302,0.00033567895,0.00034608433,0.0016526041,0.0007116491,0.0007033696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014505585,0.000035117948,0.9800016,0.000030106516,0.0000758924,0.00006734167,0.00016229317,0.000167222,0.0002644939,0.00014222757,0.014411505,0.0044972566],"study_design_scores_gemma":[0.000039402916,0.000030381845,0.99392974,0.000025423358,0.000035960682,0.00004421498,0.00012474447,0.00034378716,0.00008310637,0.000037829283,0.005298284,0.0000071508684],"about_ca_topic_score_codex":0.9166604,"about_ca_topic_score_gemma":0.9354462,"teacher_disagreement_score":0.08333957,"about_ca_system_score_codex":0.0066852444,"about_ca_system_score_gemma":0.013458655,"threshold_uncertainty_score":0.16766071},"labels":[],"label_agreement":null},{"id":"W2028602994","doi":"10.1016/s1873-9954(09)70037-0","title":"P023 CROHN'S DISEASE PRESENTATION IN PEDIATRIC PATIENTS","year":2009,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Presentation (obstetrics); Crohn's disease; Medicine; Disease; Pediatrics; Intensive care medicine; Internal medicine; Surgery","score_opus":0.006429205289719926,"score_gpt":0.24443606949080082,"score_spread":0.2380068642010809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028602994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992059,0.0013057247,0.00016309074,0.0004890126,0.00003145331,0.000025998186,0.00019683587,0.000020014993,0.005708885],"genre_scores_gemma":[0.99870276,0.00066248915,0.00011713936,0.00010366251,0.000058840567,0.000010128864,0.000112066555,0.0000044057215,0.00022863451],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99979335,0.00003765184,0.000018142191,0.000036195644,0.000045538654,0.00006921575],"domain_scores_gemma":[0.99958986,0.00008579511,0.00012084889,0.000008612019,0.000026289294,0.00016862905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015816739,0.0003728653,0.00029449462,0.0007350907,0.0006852745,0.00047677846,0.000204488,0.00068466447,0.004617521],"category_scores_gemma":[0.0012823695,0.00023976139,0.00019790189,0.00073987927,0.00037875035,0.0005592963,0.0003492596,0.0006413996,0.0004974884],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022456648,0.00008889025,0.8523527,0.00007005312,0.000022062035,0.13061923,0.00036242706,0.00012378248,0.002002998,0.00026177274,0.0025846432,0.011286981],"study_design_scores_gemma":[0.00003710576,0.00025167625,0.53132904,0.00010274327,0.000026064221,0.46450195,0.0010052555,0.00026633393,0.00049452594,0.00023827232,0.0017315208,0.000015543723],"about_ca_topic_score_codex":0.0016567562,"about_ca_topic_score_gemma":0.0016425601,"teacher_disagreement_score":0.004617521,"about_ca_system_score_codex":0.00037959366,"about_ca_system_score_gemma":0.0003981863,"threshold_uncertainty_score":0.01544714},"labels":[],"label_agreement":null},{"id":"W2031417477","doi":"10.1016/s1873-9954(09)70023-0","title":"P009 DETERMINANTS OF CORTICOSTEROID-RESISTANCE IN SEVERE PEDIATRIC ULCERATIVE COLITIS","year":2009,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Ulcerative colitis; Corticosteroid; Medicine; Resistance (ecology); Internal medicine; Gastroenterology; Biology; Disease","score_opus":0.012343497250717272,"score_gpt":0.29147870562679923,"score_spread":0.27913520837608197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031417477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936149,0.0014102026,0.0001526337,0.0009360091,0.000033213084,0.000013674084,0.0006685469,0.000011266256,0.003159641],"genre_scores_gemma":[0.99900144,0.00025100447,0.00018259155,0.000054847085,0.000043844957,0.0000052658197,0.00024019845,0.0000054547277,0.0002154382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996921,0.00009132505,0.000042524156,0.000040555784,0.000092796654,0.000040726634],"domain_scores_gemma":[0.9968659,0.0009012319,0.0013519176,0.000069773734,0.00025989092,0.000551301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026665884,0.0002861829,0.00024929288,0.00039868976,0.00027786428,0.00051726925,0.00037709504,0.0005620383,0.007992299],"category_scores_gemma":[0.0037158537,0.00016755925,0.00029033047,0.00077524583,0.00027543743,0.00034442492,0.0002848735,0.0008328687,0.0008775523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012160867,0.00003955683,0.9949503,0.00001706248,0.000018467124,0.00044303245,0.000027727116,0.00005525619,0.00023368008,0.00003420722,0.0006601957,0.0033988873],"study_design_scores_gemma":[0.0000100584875,0.000083910025,0.99725217,0.000026482823,0.000015345424,0.0018691691,0.00008298649,0.00022082462,0.000067584544,0.000036909623,0.00033194816,0.0000026899752],"about_ca_topic_score_codex":0.002975911,"about_ca_topic_score_gemma":0.0029293268,"teacher_disagreement_score":0.007992299,"about_ca_system_score_codex":0.00020832062,"about_ca_system_score_gemma":0.00038634523,"threshold_uncertainty_score":0.026736915},"labels":[],"label_agreement":null},{"id":"W2040332548","doi":"10.1016/s1873-9954(08)70054-5","title":"P043 LONG-TERM STEROID-FREE REMISSION IN CROHN'S PATIENTS RECEIVING ADALIMUMAB: THE CHARM TRIAL","year":2008,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Charm (quantum number); Adalimumab; Term (time); Medicine; Steroid use; Crohn's disease; Internal medicine; Physics; Particle physics","score_opus":0.012253515520056706,"score_gpt":0.25624824434338095,"score_spread":0.24399472882332424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040332548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9474771,0.032394685,0.00036575392,0.00517184,0.0006989665,0.00032927224,0.0022414783,0.00013542965,0.011185556],"genre_scores_gemma":[0.9861502,0.0050294683,0.0004960561,0.0026952722,0.0005233866,0.00034810175,0.0013014852,0.000017867216,0.003438096],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996898,0.00015883178,0.00001962758,0.000028331262,0.000041566018,0.00006173498],"domain_scores_gemma":[0.99940586,0.00013377174,0.000117684656,0.00004792631,0.000030457952,0.0002642819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082050846,0.00041554507,0.00082241575,0.00016023108,0.0005635507,0.000811449,0.00041243603,0.0009862154,0.0036695267],"category_scores_gemma":[0.001020936,0.00015796075,0.000962489,0.00032548982,0.00042326757,0.0005492417,0.00034398734,0.0022925788,0.00072258676],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75436896,0.0033824656,0.013479261,0.002233607,0.00323885,0.0006161393,0.00015402117,0.0010067195,0.006082866,0.0013555601,0.029084578,0.18499695],"study_design_scores_gemma":[0.7068184,0.11871061,0.13897231,0.0009981486,0.003274203,0.0017742746,0.00028011634,0.002322833,0.0019402537,0.0032135337,0.021563036,0.00013220792],"about_ca_topic_score_codex":0.00064316066,"about_ca_topic_score_gemma":0.0025888004,"teacher_disagreement_score":0.0036695267,"about_ca_system_score_codex":0.00039958107,"about_ca_system_score_gemma":0.0005103559,"threshold_uncertainty_score":0.012275815},"labels":[],"label_agreement":null},{"id":"W2041701536","doi":"10.1016/s1873-9954(09)70035-7","title":"P021 TRANSIENT HYPERTRANSAMINASEMIA IN PEDIATRIC PATIENTS WITH CROHN'S DISEASE UNDERGOING INITIAL TREATMENT WITH ENTERAL NUTRITION","year":2009,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Parenteral nutrition; Enteral administration; Crohn's disease; Crohn disease; Pediatrics; Disease; Intensive care medicine; Internal medicine","score_opus":0.0046758147378076625,"score_gpt":0.2249151943841396,"score_spread":0.22023937964633195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041701536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571735,0.0019086627,0.00012084403,0.00022034519,0.000023762947,0.000016337983,0.00019876102,0.000013775738,0.0017801579],"genre_scores_gemma":[0.9985923,0.0008310574,0.00013827343,0.00006173211,0.00003311658,0.000012673464,0.00018691667,0.0000033662075,0.00014045536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996928,0.000070168724,0.000036771442,0.000048821497,0.00008591645,0.00006554456],"domain_scores_gemma":[0.99889576,0.00034144882,0.00039020198,0.000018375731,0.00007876094,0.00027548056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020999539,0.00039417503,0.0005547886,0.0008910304,0.00045417843,0.00044485508,0.00020626784,0.00063806697,0.001670802],"category_scores_gemma":[0.0024590571,0.00022738522,0.00032030375,0.00078374194,0.00033833325,0.00039057835,0.00022744616,0.000761603,0.00021140084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004701096,0.00007614751,0.97270995,0.000066270004,0.000028012384,0.018862605,0.0001364109,0.00007878281,0.0012360398,0.000040194827,0.00051940995,0.005776191],"study_design_scores_gemma":[0.000030711995,0.00056693173,0.93463814,0.00005075523,0.000053517128,0.063007094,0.00027002173,0.0002046909,0.0005725248,0.000036539735,0.00055935455,0.000009708817],"about_ca_topic_score_codex":0.0023865758,"about_ca_topic_score_gemma":0.0018685696,"teacher_disagreement_score":0.0023865758,"about_ca_system_score_codex":0.00048356733,"about_ca_system_score_gemma":0.00039025626,"threshold_uncertainty_score":0.0055894256},"labels":[],"label_agreement":null},{"id":"W2044870710","doi":"10.1016/s1873-9954(09)70024-2","title":"P010 PANETH CELLS: A SOURCE OF THE PRO-INFLAMMATORY CYTOKINE TNF-ALPHA","year":2009,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Cytokine; Tumor necrosis factor alpha; Alpha (finance); Cell biology; Immunology; Medicine; Biology","score_opus":0.00933684671081425,"score_gpt":0.22516806489024657,"score_spread":0.21583121817943232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044870710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95028365,0.014815936,0.012003581,0.0019298366,0.0004752401,0.000088216366,0.0012770912,0.00032940335,0.018797105],"genre_scores_gemma":[0.96231866,0.0048032464,0.008160563,0.000275054,0.00016216259,0.00009590258,0.0015550412,0.00006896058,0.022560332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998939,0.000016856191,0.000009404834,0.000022542505,0.00003873544,0.000018540959],"domain_scores_gemma":[0.9998926,0.000025078902,0.000014244247,0.000014069196,0.000014862754,0.000039085124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001478324,0.000277595,0.00018142606,0.00021908102,0.00014314298,0.0005525811,0.000114998606,0.00028041808,0.0034422446],"category_scores_gemma":[0.00021108301,0.00012797267,0.0001390187,0.00014623663,0.00013454145,0.00033082828,0.00026549495,0.00092340226,0.0014058957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030662864,0.00003594172,0.00046986676,0.00009302617,0.00000608538,0.0002641694,0.00003721524,0.000023815026,0.98931843,0.00032685336,0.00064690254,0.008470977],"study_design_scores_gemma":[0.00021880283,0.00085041864,0.010665202,0.000075801574,0.00006942271,0.0044585317,0.00018180783,0.0010509288,0.93837625,0.0006098084,0.043430664,0.0000122753345],"about_ca_topic_score_codex":0.00019676094,"about_ca_topic_score_gemma":0.00033173215,"teacher_disagreement_score":0.0034422446,"about_ca_system_score_codex":0.00012737734,"about_ca_system_score_gemma":0.00023298274,"threshold_uncertainty_score":0.011515498},"labels":[],"label_agreement":null},{"id":"W2046667750","doi":"10.1016/s1873-9954(07)70024-1","title":"P012 CD-68 POSITIVE CELLS IN BUCCAL MUCOSA AS DIAGNOSTIC MARKER FOR IBD","year":2007,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Buccal mucosa; Ulcerative colitis; Medicine; Buccal administration; Inflammatory bowel disease; Saliva; Candida albicans; Gastrointestinal tract; Gastroenterology; Pathology; Population; Oral cavity; Oral mucosa; Internal medicine; Disease; Dentistry; Biology; Microbiology","score_opus":0.005839724707012261,"score_gpt":0.2519954179815904,"score_spread":0.24615569327457815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046667750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849054,0.0069504334,0.00057373097,0.00013427284,0.00006578225,0.0000409495,0.00014098323,0.00004742539,0.0071410732],"genre_scores_gemma":[0.9964929,0.0013574141,0.00064015924,0.00004995288,0.000040933166,0.000013529888,0.00014963107,0.000004302289,0.0012510411],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998253,0.000030421257,0.000019735018,0.000028599039,0.000047294016,0.000048614373],"domain_scores_gemma":[0.999895,0.000027875065,0.0000120748155,0.000008697902,0.000020375695,0.000035988178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020357038,0.00025136166,0.0001541917,0.0014317716,0.00025560084,0.0005535049,0.00017040192,0.0006603682,0.0040183445],"category_scores_gemma":[0.00041996627,0.00016382795,0.00012917502,0.00036182953,0.0003315959,0.00021711052,0.0002762198,0.0003133236,0.0010398721],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038000145,0.00048773564,0.25988713,0.0005517558,0.00007249605,0.046510708,0.0005594333,0.00009637004,0.62469894,0.00054473506,0.0030966564,0.059694007],"study_design_scores_gemma":[0.00023075852,0.0018346768,0.7454262,0.00023912759,0.0002767769,0.14593047,0.0013254741,0.0013644417,0.08861739,0.00036269362,0.014347157,0.00004484594],"about_ca_topic_score_codex":0.0008949153,"about_ca_topic_score_gemma":0.00068630517,"teacher_disagreement_score":0.0040183445,"about_ca_system_score_codex":0.00017159936,"about_ca_system_score_gemma":0.00010259919,"threshold_uncertainty_score":0.013442695},"labels":[],"label_agreement":null},{"id":"W2054399435","doi":"10.1016/s1873-9954(07)70080-0","title":"P068 NATALIZUMAB MAINTAINS REMISSION FOR 2 YEARS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE AND IN THOSE WITH PRIOR INFLIXIMAB EXPOSURE: RESULTS FROM AN OPEN-LABEL EXTENSION STUDY","year":2007,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Natalizumab; Infliximab; Crohn's disease; Medicine; Open label; Disease; Internal medicine; Extension (predicate logic); Gastroenterology; Adverse effect; Computer science","score_opus":0.0167947458870927,"score_gpt":0.2927308397466874,"score_spread":0.2759360938595947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054399435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652404,0.0023308147,0.00008874228,0.00015293626,0.000036921418,0.00009257618,0.0001690993,0.000014921031,0.0005899793],"genre_scores_gemma":[0.998069,0.00071842514,0.00019696531,0.0001902434,0.00009527763,0.0000827204,0.0003025244,0.0000035878613,0.00034128758],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993467,0.00031533028,0.000060497925,0.0000803451,0.00008506731,0.00011211507],"domain_scores_gemma":[0.998898,0.0002854004,0.00026805696,0.00010892017,0.000059642593,0.00037989367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012720483,0.0005230488,0.0012672619,0.00025802094,0.00035139924,0.00058172253,0.00039099617,0.000883327,0.0015653111],"category_scores_gemma":[0.0015061614,0.00025142112,0.0010597015,0.0002751865,0.00046295696,0.00066337956,0.0002589629,0.0015361366,0.00038965975],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.705733,0.025161967,0.053906135,0.0007865106,0.0024329366,0.00085932907,0.0004896452,0.0005856148,0.03580038,0.00012572652,0.0019790598,0.1721396],"study_design_scores_gemma":[0.20569812,0.4950891,0.28883642,0.00010469705,0.0016492906,0.0014903502,0.00017297264,0.00090155966,0.0027138875,0.00016378351,0.0031141725,0.00006559552],"about_ca_topic_score_codex":0.0005421387,"about_ca_topic_score_gemma":0.0010498551,"teacher_disagreement_score":0.0015653111,"about_ca_system_score_codex":0.00023889085,"about_ca_system_score_gemma":0.0002705452,"threshold_uncertainty_score":0.006727338},"labels":[],"label_agreement":null},{"id":"W2058023266","doi":"10.1016/s1873-9954(09)70025-4","title":"P011 FAECAL OSTEOPROTEGRIN IN PAEDIATRIC CROHN DISEASE","year":2009,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Crohn's disease; Medicine; Disease; Internal medicine","score_opus":0.006954247403952481,"score_gpt":0.24908127611164832,"score_spread":0.24212702870769584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058023266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8714947,0.09817507,0.00084437185,0.0074110315,0.00087663974,0.00009199525,0.0013226947,0.000119408876,0.019664172],"genre_scores_gemma":[0.9737983,0.019604636,0.0016218959,0.0005591281,0.0003317777,0.000037894337,0.0005866087,0.000012109875,0.0034475923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997664,0.00008686029,0.00002721595,0.00002181262,0.00007546631,0.000022313907],"domain_scores_gemma":[0.99949086,0.00014994892,0.00014067536,0.000011201426,0.00006810879,0.00013906666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033667716,0.00032576083,0.0004285476,0.00079794216,0.00030553268,0.00031850048,0.00019537064,0.0007148873,0.0031777523],"category_scores_gemma":[0.0014346493,0.00016417027,0.00019256688,0.00050402526,0.00035380336,0.00020772537,0.0002771684,0.000784648,0.00052336545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0091822175,0.00048857165,0.63972443,0.0014255814,0.00024111007,0.0335307,0.00025106172,0.00041337416,0.019134039,0.0009867315,0.023880264,0.27074194],"study_design_scores_gemma":[0.0008255364,0.00403595,0.8325943,0.00081617775,0.00025777795,0.11515781,0.0003280514,0.00069608144,0.009264669,0.0006935546,0.035301894,0.000028188426],"about_ca_topic_score_codex":0.0018145285,"about_ca_topic_score_gemma":0.0022614864,"teacher_disagreement_score":0.0031777523,"about_ca_system_score_codex":0.0003629347,"about_ca_system_score_gemma":0.00040162518,"threshold_uncertainty_score":0.010630667},"labels":[],"label_agreement":null},{"id":"W2072542127","doi":"10.1016/s1873-9954(09)70005-9","title":"O04 INCIDENCE AND PREVALENCE OF CHILDHOOD-ONSET INFLAMMATORY BOWEL DISEASE IN ONTARIO, CANADA: RESULTS FROM THE ONTARIO CROHN'S AND COLITIS COHORT (OCCC)","year":2009,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Microscopic Colitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Cohort; Inflammatory bowel disease; Crohn's disease; Internal medicine; Disease; Ulcerative colitis; Cohort study; Pediatrics; Gastroenterology","score_opus":0.006862195644053836,"score_gpt":0.23205383099571106,"score_spread":0.22519163535165723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072542127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650012,0.0013785837,0.00009759061,0.0004865854,0.00002798528,0.000051111612,0.027786113,0.000020397058,0.005150406],"genre_scores_gemma":[0.98951906,0.00077941024,0.000115429364,0.00011342153,0.000011808733,0.000019808653,0.007883673,0.0000064279607,0.0015510464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946576,0.00003429309,0.000039236318,0.000061864346,0.00021820428,0.00018068287],"domain_scores_gemma":[0.9986619,0.00004699024,0.0003777211,0.00004976116,0.0005293834,0.00033420793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002816415,0.00021597823,0.00025618394,0.0011308964,0.0010615102,0.0005915164,0.0008233128,0.00046037327,0.0025207826],"category_scores_gemma":[0.0012309854,0.0003343178,0.00044402637,0.0028700556,0.0003972699,0.00024265955,0.0005385818,0.00038940166,0.00026271128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060628405,0.000013337816,0.99555224,0.000020133855,0.0000422429,0.000041382693,0.00013688933,0.00005058982,0.000110075925,0.00004009571,0.002642455,0.0012899747],"study_design_scores_gemma":[0.0000053408276,0.000007858674,0.99923086,0.0000136614,0.000012813824,0.00002679728,0.00014219429,0.000053918895,0.000010367781,0.0000044826033,0.00048941857,0.000002314702],"about_ca_topic_score_codex":0.98854744,"about_ca_topic_score_gemma":0.9930595,"teacher_disagreement_score":0.011452556,"about_ca_system_score_codex":0.008545604,"about_ca_system_score_gemma":0.009696445,"threshold_uncertainty_score":0.062003016},"labels":[],"label_agreement":null},{"id":"W2082377475","doi":"10.1016/s1873-9954(07)70026-5","title":"P014 ESOPHAGEAL STRICTURES IN EOSINOPHILIC ESOPHAGITIS: DILATION IS AN EFFECTIVE AND SAFE ALTERNATIVE AFTER FAILURE OF TOPICAL CORTICOSTEROIDS","year":2007,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Eosinophilic esophagitis; Medicine; Dilation (metric space); Dermatology; Gastroenterology; Internal medicine; Disease","score_opus":0.008486025470570124,"score_gpt":0.28672944734208516,"score_spread":0.278243421871515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082377475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68082094,0.21875975,0.005704747,0.026972009,0.0048549324,0.00023984908,0.00026003487,0.0004915345,0.061896242],"genre_scores_gemma":[0.9597511,0.02200595,0.00235224,0.0027231246,0.005403972,0.000048753354,0.00016644294,0.0000320898,0.0075162495],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998597,0.00005145864,0.000016091855,0.000014840905,0.000030584248,0.000027283304],"domain_scores_gemma":[0.99980253,0.000065668326,0.000035502246,0.000014238346,0.000014660187,0.00006745744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002766847,0.0004482577,0.0007343839,0.00048174663,0.0004025466,0.00028581536,0.00023523517,0.0017304181,0.0066762385],"category_scores_gemma":[0.00071040663,0.00009608464,0.00047471875,0.00017730588,0.00047094875,0.0004816075,0.00023959843,0.0011612561,0.0016891903],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024463717,0.0025114184,0.016531449,0.0023643724,0.00033115444,0.11569808,0.00019493555,0.0002584916,0.046890028,0.002633129,0.052299026,0.73582417],"study_design_scores_gemma":[0.0075965393,0.06215278,0.25419477,0.0017265192,0.00066894153,0.48503655,0.00058772677,0.001674974,0.0343341,0.0047373236,0.14710633,0.00018342167],"about_ca_topic_score_codex":0.00016998696,"about_ca_topic_score_gemma":0.00042998494,"teacher_disagreement_score":0.0066762385,"about_ca_system_score_codex":0.00013335705,"about_ca_system_score_gemma":0.0001489481,"threshold_uncertainty_score":0.022334218},"labels":[],"label_agreement":null},{"id":"W2083269457","doi":"10.1016/s1873-9954(08)70010-7","title":"9 ASSESSMENT OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF CROHN'S DISEASE IN PATIENTS FOR WHOM INFLIXIMAB TREATMENT WAS NOT SUCCESSFUL: OPEN-LABEL INDUCTION PRELIMINARY RESULTS FROM THE WELCOME STUDY","year":2008,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Certolizumab pegol; Infliximab; Medicine; Crohn's disease; Open label; Adalimumab; Disease; Internal medicine; Clinical trial","score_opus":0.06588458941485871,"score_gpt":0.3734134110423851,"score_spread":0.3075288216275264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083269457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841999,0.011533256,0.00046015964,0.0011211943,0.00014620335,0.0003002915,0.00066377653,0.0000402406,0.001534947],"genre_scores_gemma":[0.99511635,0.0019546351,0.0007825631,0.00048837904,0.00026080536,0.00018826946,0.0006469928,0.000012736902,0.0005492229],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99810946,0.001251595,0.00011900094,0.00016709766,0.00022910921,0.00012375094],"domain_scores_gemma":[0.9946167,0.0026631018,0.0011494575,0.0003065891,0.0003286502,0.00093549746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035399373,0.0005761368,0.001822235,0.00024776263,0.00027422345,0.00092713983,0.00043213626,0.0016478483,0.0015919685],"category_scores_gemma":[0.0053356686,0.00024202459,0.0009956316,0.00022114824,0.00063194806,0.00092751934,0.00031134134,0.0021479311,0.00046605236],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76999253,0.0069815237,0.036944885,0.0006502805,0.0009165236,0.00037760191,0.00029573316,0.0005429961,0.013211988,0.00012842222,0.0018832029,0.16807422],"study_design_scores_gemma":[0.39168215,0.3872895,0.20081717,0.00037714624,0.0018578983,0.0012020179,0.00019947067,0.0027286338,0.006612063,0.00048511772,0.006603263,0.00014558778],"about_ca_topic_score_codex":0.00051439804,"about_ca_topic_score_gemma":0.00096238544,"teacher_disagreement_score":0.0035399373,"about_ca_system_score_codex":0.0006175113,"about_ca_system_score_gemma":0.0005241797,"threshold_uncertainty_score":0.018721163},"labels":[],"label_agreement":null},{"id":"W3022084089","doi":"10.1016/s1873-9954(09)70009-6","title":"O08 METHOTREXATE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: AN 8 YEAR RETROSPECTIVE STUDY IN A CANADIAN PEDIATRIC IBD CENTER","year":2009,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Inflammatory bowel disease; Medicine; Methotrexate; Retrospective cohort study; Center (category theory); Disease; Inflammatory Bowel Diseases; Internal medicine; Pediatrics","score_opus":0.007548643257987481,"score_gpt":0.26978055570779896,"score_spread":0.2622319124498115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022084089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964281,0.0013267206,0.000047003818,0.00027727403,0.000011502271,0.000021759533,0.00037945373,0.0000056545614,0.0015026563],"genre_scores_gemma":[0.99787474,0.0010733022,0.000118282056,0.00020116523,0.000021873846,0.000011801034,0.0003173544,0.000006138789,0.00037532445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983726,0.00012343313,0.00011361674,0.00019577237,0.00071438524,0.0004802642],"domain_scores_gemma":[0.99625176,0.0002131869,0.0015844353,0.00011389905,0.0010132304,0.0008235419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006208331,0.00039439794,0.00047187778,0.0014338543,0.002505431,0.0010155472,0.0010352288,0.0009118879,0.001326175],"category_scores_gemma":[0.0021030286,0.000469946,0.0006299588,0.00338005,0.000781854,0.00037244803,0.00060245197,0.0012033978,0.00019809882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010193442,0.000060550145,0.99471384,0.000019381006,0.000043154338,0.0014539701,0.000515828,0.00003224263,0.00029282106,0.00003912712,0.00030665705,0.0024205197],"study_design_scores_gemma":[0.000010721347,0.00016059776,0.9948596,0.000036458096,0.000049969312,0.002517921,0.0012354186,0.000062035404,0.00009972227,0.0000072521025,0.0009451925,0.000015037071],"about_ca_topic_score_codex":0.7603917,"about_ca_topic_score_gemma":0.7875131,"teacher_disagreement_score":0.7603917,"about_ca_system_score_codex":0.007478998,"about_ca_system_score_gemma":0.011268406,"threshold_uncertainty_score":0.48203874},"labels":[],"label_agreement":null},{"id":"W4232555127","doi":"10.1016/s1873-9954(08)70011-9","title":"10 LONG TERM OUTCOME AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY IN A COHORT OF 955 CANADIAN PATIENTS","year":2008,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cohort; Quality of life (healthcare); Medicine; Proctocolectomy; Outcome (game theory); Term (time); Internal medicine; Ulcerative colitis; Nursing; Disease","score_opus":0.035231636552715495,"score_gpt":0.32367154848711177,"score_spread":0.2884399119343963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232555127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976127,0.00035864062,0.000018808762,0.00011188404,0.0000070280526,0.000015350459,0.0012165103,0.0000023168545,0.0006567912],"genre_scores_gemma":[0.99799985,0.00029537707,0.000041567044,0.00007581657,0.000007846349,0.00001181799,0.001249926,0.0000015617958,0.00031615075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960774,0.000016851849,0.000019448666,0.00006112413,0.00013594597,0.00015896361],"domain_scores_gemma":[0.9993499,0.000037094436,0.00016746113,0.00003167842,0.00014446228,0.00026935624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002909628,0.00034305904,0.0003621194,0.0008101341,0.0017586615,0.00082618796,0.0007336676,0.00058513856,0.0013862851],"category_scores_gemma":[0.0009320838,0.00031044678,0.00053592277,0.0014659984,0.00057365274,0.00034613642,0.0005143316,0.00082395325,0.00021888225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014845228,0.000041284457,0.9974376,0.000011911327,0.000058547135,0.00014481273,0.00023308051,0.000045730685,0.00019741108,0.000033492146,0.0004150577,0.0012325598],"study_design_scores_gemma":[0.000009364682,0.000071648596,0.9990835,0.0000108670965,0.000022372684,0.00011439242,0.00032023335,0.00006201994,0.000021745316,0.000009006012,0.0002663709,0.000008350293],"about_ca_topic_score_codex":0.8500125,"about_ca_topic_score_gemma":0.86401004,"teacher_disagreement_score":0.14998752,"about_ca_system_score_codex":0.0060273255,"about_ca_system_score_gemma":0.0047046826,"threshold_uncertainty_score":0.3017416},"labels":[],"label_agreement":null},{"id":"W4249611568","doi":"10.1016/s1873-9954(08)70025-9","title":"P014 IS SOCIOECONOMIC DEPRIVATION ASSOCIATED WITH A MORE SEVERE CROHN'S DISEASE ?","year":2008,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Dermatological and COVID-19 studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Crohn's disease; Socioeconomic status; Medicine; Disease; Social deprivation; Internal medicine; Environmental health; Political science","score_opus":0.020073067888793022,"score_gpt":0.2737208167304118,"score_spread":0.2536477488416188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249611568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96025026,0.015007394,0.00024244277,0.011944011,0.0003477873,0.000016628248,0.0009401181,0.0000072159824,0.011244157],"genre_scores_gemma":[0.99744534,0.0013268718,0.000049407732,0.0003502429,0.00021587698,0.0000030787646,0.00014426593,0.000002765723,0.00046201295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992594,0.0003269347,0.00007510188,0.00010581553,0.00013409289,0.000098618126],"domain_scores_gemma":[0.99715185,0.0009411657,0.0010750768,0.0001490317,0.00017604037,0.0005068321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009434157,0.00029411947,0.00035050692,0.001013001,0.00068673503,0.0011316512,0.00038335283,0.0013435532,0.012475879],"category_scores_gemma":[0.004860438,0.00018882338,0.0011057984,0.001402135,0.0007869217,0.00069532526,0.00059557764,0.00094091834,0.00042838667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007546908,0.0000666538,0.98623395,0.00014180464,0.0006324803,0.00052627857,0.00016836249,0.00004144356,0.00023428534,0.00046251406,0.0015910026,0.009146462],"study_design_scores_gemma":[0.00003885408,0.00014831143,0.9951627,0.00018386015,0.00037753079,0.0007953385,0.00060609134,0.00015255062,0.00006504712,0.00079538976,0.001662901,0.000011388878],"about_ca_topic_score_codex":0.0073159286,"about_ca_topic_score_gemma":0.008654277,"teacher_disagreement_score":0.012475879,"about_ca_system_score_codex":0.00023481992,"about_ca_system_score_gemma":0.00040991293,"threshold_uncertainty_score":0.041735947},"labels":[],"label_agreement":null}]}